BEDROSIAN CAMILLE L (Chief Medical Officer) sold 3.5% of their position (10.03K shares) of AMYLYX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $324.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/14/2026ACC: 0001193125-26-390510
Officer· Chief Medical Officer
Since Mar 2026
-10.03K
Net shares
Net seller
$324.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7.95K
Price / share
$32.21
Trade value
$256K
% of position
2.8%
9/10/2026
288.09K→280.14K
Common Stock
Direct
Shares
−2.08K
Price / share
$33.09
Trade value
$68.86K
% of position
0.7%
9/10/2026
280.14K→278.06K
Total
Net shares
−10.03K
Net value
-$324.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2026 | S · Sale | −7.95K | $32.21 | $256K | 2.8% | 288.09K | 280.14K |
| Common Stock Direct | 9/10/2026 | S · Sale | −2.08K | $33.09 | $68.86K | 0.7% | 280.14K | 278.06K |
| Total | −10.03K | -$324.87K | ||||||
Derivative Transactions0
No derivative transactions reported